| Literature DB >> 27243016 |
Ferdinand Köckerling1, Marinos Damianos Botsinis1, Christine Rohde1, Wolfgang Reinpold2.
Abstract
INTRODUCTION: Symptomatic umbilical and/or epigastric hernias are often seen concomitantly with rectus abdominis diastasis (RAD), and suture repair of such defects has a high recurrence rate. In the literature, there are reports of both endoscopic and open techniques for repair of symptomatic umbilical and/or epigastric hernias in association with RAD. This paper now reports on the early results of a hybrid technique used for reconstruction of the linea alba and mesh augmentation [endoscopic-assisted linea alba reconstruction plus mesh augmentation (ELAR plus)].Entities:
Keywords: epigastric hernia; linea alba reconstruction; rectus abdominis diastasis; umbilical hernia; video-endoscopic technique
Year: 2016 PMID: 27243016 PMCID: PMC4865488 DOI: 10.3389/fsurg.2016.00027
Source DB: PubMed Journal: Front Surg ISSN: 2296-875X
Figure 1Clinical findings of a patient with rectus abdominis diastasis, and umbilical and epigastric hernia when beginning to sit up.
Figure 2CT scan of the patient with rectus abdominis diastasis, and umbilical and epigastric hernia.
Figure 3Extent of incision and relation of mesh placement to linea alba reconstruction.
Figure 4Incision of right rectus sheath following dissection of the latter.
Figure 5New linea alba after suturing together the medial portions of the two rectus sheaths at the midline. Both rectus abdominis muscles are repositioned beside the reconstructed linea alba.
Figure 6Replacement of the medial segments of the rectus sheaths used to reconstruct the linea with a middle-weight, large-pore polypropylene mesh (TiMesh strong).
Patient characteristics, mean operating time, and mean mesh size.
| Sex | 29 men/11 women | |
| Age | Mean: 53.6 years | 25–76 years |
| BMI | Mean: 32.6 | 23–50 |
| ASA | Mean: 1.9 | 1–3 |
| OR duration | Mean: 120 min | 67–179 |
| Mesh length (TiMesh strong) | Mean: 18.6 cm | 15–22 |
| Mesh width (TiMesh strong) | Mean: 9.1 cm | 5–13 |
Postoperative complication rate at the end of in-hospital treatment.
| None | 95% | |
| Umbilical necrosis | 2.5% | |
| Seroma | 2.5% |
Results of 30-day follow-up visit.
| Discrete impaired umbilical wound healing | 5.0% | |
| Intermittent pain on exertion | 7.5% | |
| Painkillers still used when required | 5.0% |